| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Miller Robert E is a Chief Financial Officer at Sonoma Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 15 buys and 0 sells.
Estimated insider holdings value: $23K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 13, 2018 | SNOA Sonoma Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 2,400 | $4.06 | $9,755.52 | +7.0% | |
| Mar 12, 2018 | SNOA Sonoma Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 2,400 | $3.97 | $9,516.00 | +8.2% | |
| Nov 29, 2017 | SNOA Sonoma Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 1,790 | $5.02 | $8,990.80 | +7.1% | |
| Nov 21, 2017 | SNOA Sonoma Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 2,000 | $5.03 | $10,065.00 | +9.1% | |
| Aug 10, 2017 | SNOA Sonoma Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 2,264 | $5.30 | $11,999.20 | +26.7% | |
| Mar 9, 2017 | SNOA Sonoma Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 750 | $7.02 | $5,267.50 | +3.1% | |
| Mar 8, 2017 | SNOA Sonoma Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 1,000 | $6.93 | $6,930.00 | +7.3% | |
| Dec 8, 2016 | SNOA Sonoma Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 5,000 | $4.86 | $24,300.00 | +291.7% |